EHTH / eHealth, Inc. - SEC-Einreichungen, Jahresbericht, Proxy Statement

eHealth, Inc.
US ˙ NasdaqGS ˙ US28238P1093

Basisstatistiken
LEI 5299003O8Y5OKXUZQ421
CIK 1333493
SEC Filings
All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis. These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to eHealth, Inc.
SEC Filings (Chronological Order)
Auf dieser Seite finden Sie eine vollständige, chronologische Liste der SEC-Einreichungen, mit Ausnahme der Eigentumseinreichungen, die wir an anderer Stelle bereitstellen.
May 7, 2026 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2026 ☐ TRANSITION REPORT PURSUANT TO

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2026 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-33071 EHEALTH, INC. (Exact

May 6, 2026 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (date of earliest event reported): May 3, 2026 EHEALTH, INC. (Exact

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (date of earliest event reported): May 3, 2026 EHEALTH, INC. (Exact Name of Registrant as Specified in its Charter) Delaware 001-33071 56-2357876 (State or other jurisdiction of incorporation) (Commission File Number)

May 6, 2026 EX-99.2

©2026 eHealthInsurance Services, Inc. 1 Q1 2026 Financial Results ©2026 eHealthInsurance Services, Inc. 2 Safe Harbor Statement Forward-Looking Statements This presentation includes forward-looking statements within the meaning of the Private Securit

a1q26earningsslidesfinal ©2026 eHealthInsurance Services, Inc. 1 Q1 2026 Financial Results ©2026 eHealthInsurance Services, Inc. 2 Safe Harbor Statement Forward-Looking Statements This presentation includes forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements generally relate to future events or our future financial or op

May 6, 2026 EX-99.1

eHealth, Inc. Announces First Quarter 2026 Results Q1 2026 results ahead of expectations Strong Medicare segment profitability and operating expense improvements YoY Launches lifetime advisory model and final expense insurance offering On track to re

eHealth, Inc. Announces First Quarter 2026 Results Q1 2026 results ahead of expectations Strong Medicare segment profitability and operating expense improvements YoY Launches lifetime advisory model and final expense insurance offering On track to reduce total FY 2026 operating costs by approximately $90M INDIANAPOLIS — May 6, 2026 — eHealth, Inc. (Nasdaq: EHTH), a leading private online health in

April 28, 2026 DEFA14A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a party other than the Registrant ☐

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, For Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☐ Definitive Proxy State

April 28, 2026 DEF 14A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a party other than the Registrant ☐

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, For Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☒ Definitive Proxy State

March 31, 2026 EX-99.1

Andrea Brimmer to Transition from eHealth Board of Directors

Andrea Brimmer to Transition from eHealth Board of Directors INDIANAPOLIS, March 31, 2026 – eHealth, Inc.

March 31, 2026 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (date of earliest event reported): March 26, 2026 EHEALTH, INC. (Exa

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (date of earliest event reported): March 26, 2026 EHEALTH, INC. (Exact Name of Registrant as Specified in its Charter) Delaware 001-33071 56-2357876 (State or other jurisdiction of incorporation) (Commission File Numbe

February 26, 2026 EX-21.1

Subsidiaries of the Registrant

Exhibit 21.1 Subsidiaries of the Registrant Subsidiary State or Other Jurisdiction of Incorporation or Organization Amplify Engagement Solutions Insurance Agency, LLC Delaware eHealthInsurance Services, Inc. Delaware eHealth China, Inc. Delaware eHealth China (Xiamen) Technology Co., Ltd. China

February 26, 2026 EX-19

EHEALTH, INC. INSIDER TRADING POLICY (As Amended on December 16, 2025)

EHEALTH, INC. INSIDER TRADING POLICY (As Amended on December 16, 2025) A.POLICY OVERVIEW eHealth, Inc. (together with any subsidiaries, collectively the “Company”) has adopted this Insider Trading Policy (the “Policy”) to help you comply with the federal and state securities laws and regulations that govern trading in securities and to help the Company minimize its own legal and reputational risk.

February 26, 2026 10-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2025 ☐ TRANSITION REPORT PURSUANT TO SECTI

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2025 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-33071 EHEALTH, INC. (Exact name

February 25, 2026 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (date of earliest event reported): February 25, 2026 EHEALTH, INC. (

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (date of earliest event reported): February 25, 2026 EHEALTH, INC. (Exact Name of Registrant as Specified in its Charter) Delaware 001-33071 56-2357876 (State or other jurisdiction of incorporation) (Commission File Nu

February 25, 2026 EX-99.1

eHealth, Inc. Announces Fourth Quarter and Fiscal Year 2025 Results Achieves record-breaking quarterly revenue Ends FY’25 with highest ever commissions receivable balance of $1.1 billion Increases financial flexibility with $125.0 million asset-based

eHealth, Inc. Announces Fourth Quarter and Fiscal Year 2025 Results Achieves record-breaking quarterly revenue Ends FY’25 with highest ever commissions receivable balance of $1.1 billion Increases financial flexibility with $125.0 million asset-based revolving credit facility Launches AI voice agent at scale during Medicare Annual Enrollment Period INDIANAPOLIS, Indiana — February 25, 2026 — eHeal

February 25, 2026 EX-99.2

©2026 eHealthInsurance Services, Inc. 1 ©2026 eHealthInsurance Services, Inc. 2 Safe Harbor Statement Forward-Looking Statements This presentation includes forward-looking statements within the meaning of the Private Securities Litigation Reform Act

q4fy2025earningsslidesfi ©2026 eHealthInsurance Services, Inc. 1 ©2026 eHealthInsurance Services, Inc. 2 Safe Harbor Statement Forward-Looking Statements This presentation includes forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements generally relate to future events or our future financial or operating performance. Forwa

January 6, 2026 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (date of earliest event reported): December 31, 2025 EHEALTH, INC. (

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (date of earliest event reported): December 31, 2025 EHEALTH, INC. (Exact Name of Registrant as Specified in its Charter) Delaware 001-33071 56-2357876 (State or other jurisdiction of incorporation) (Commission File Nu

January 6, 2026 EX-3.1

CERTIFICATE OF AMENDMENT TO THE CERTIFICATE OF DESIGNATIONS OF THE SERIES A PREFERRED STOCK, PAR VALUE $0.001, EHEALTH, INC.

CERTIFICATE OF AMENDMENT TO THE CERTIFICATE OF DESIGNATIONS OF THE SERIES A PREFERRED STOCK, PAR VALUE $0.

January 6, 2026 EX-99.1

eHealth Announces $125 Million Asset-Based Revolving Credit Facility Deal Further Strengthens Capital Structure and Better Positions eHealth for Long-Term Success Proceeds Used to Repay Existing Blue Torch Term Loan and Provide Strategic Capital

eHealth Announces $125 Million Asset-Based Revolving Credit Facility Deal Further Strengthens Capital Structure and Better Positions eHealth for Long-Term Success Proceeds Used to Repay Existing Blue Torch Term Loan and Provide Strategic Capital AUSTIN, Texas, Jan 6, 2026 – eHealth, Inc.

January 6, 2026 EX-10.1

CREDIT AGREEMENT dated as of December 31, 2025 EHEALTHINSURANCE SERVICES, INC. as Borrower, THE LENDERS PARTY HERETO, as Lenders, CCP AGENCY, LLC, as Agent

EXECUTION VERSION CREDIT AGREEMENT dated as of December 31, 2025 among EHEALTHINSURANCE SERVICES, INC.

January 6, 2026 EX-10.2

FIRST AMENDMENT TO INVESTMENT AGREEMENT

Execution Version FIRST AMENDMENT TO INVESTMENT AGREEMENT This First Amendment (this “Amendment”) to the Investment Agreement, dated as of February 17, 2021 (as may be amended, restated or otherwise modified from time to time in accordance with its terms, the “Agreement”), by and between eHealth, Inc.

December 18, 2025 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (date of earliest event reported): December 16, 2025 EHEALTH, INC. (

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (date of earliest event reported): December 16, 2025 EHEALTH, INC. (Exact Name of Registrant as Specified in its Charter) Delaware 001-33071 56-2357876 (State or other jurisdiction of incorporation) (Commission File Nu

December 18, 2025 EX-3.1

EHEALTH, INC. AMENDED AND RESTATED BYLAWS (As Amended on December 16, 2025) ARTICLE I STOCKHOLDERS

EHEALTH, INC. AMENDED AND RESTATED BYLAWS (As Amended on December 16, 2025) ARTICLE I STOCKHOLDERS Section 1. Annual Meeting. (1) An annual meeting of the stockholders, for the election of directors to succeed those whose terms expire and for the transaction of such other business as may properly come before the meeting, shall be held at such place, if any, on such date, and at such time as the Bo

December 18, 2025 EX-99.1

eHealth, Inc. Updates Guidance for Fiscal Year 2025 Following Strong AEP Performance

PRESS RELEASE eHealth, Inc. Updates Guidance for Fiscal Year 2025 Following Strong AEP Performance AUSTIN, Texas, December 18, 2025 — eHealth, Inc. (Nasdaq: EHTH), a leading private online health insurance marketplace, today provided commentary on its Annual Enrollment Period (AEP) performance and updated its guidance ranges for the fiscal year ending December 31, 2025. “Our brand strength, best-i

December 4, 2025 LETTER

LETTER

December 4, 2025 John Dolan Chief Financial Officer eHealth, Inc. 13620 Ranch Road 620 N, Suite A250 Austin, TX 78717 Re: eHealth, Inc. Form 10-K for Fiscal Year Ended December 31, 2024 File No. 001-33071 Dear John Dolan: We have completed our review of your filing. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding

November 6, 2025 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2025 ☐ TRANSITION REPORT PURSUANT

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2025 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-33071 EHEALTH, INC. (E

November 5, 2025 EX-99.2

©2025 eHealthInsurance Services, Inc. Q3 2025 Financial Results 1 ©2025 eHealthInsurance Services, Inc. 2 Safe Harbor Statement Forward-Looking Statements This presentation includes forward-looking statements within the meaning of the federal securit

a3q25earningsslides1135p ©2025 eHealthInsurance Services, Inc. Q3 2025 Financial Results 1 ©2025 eHealthInsurance Services, Inc. 2 Safe Harbor Statement Forward-Looking Statements This presentation includes forward-looking statements within the meaning of the federal securities laws. Forward-looking statements generally relate to future events or our future financial or operating performance. Forw

November 5, 2025 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (date of earliest event reported): November 5, 2025 EHEALTH, INC. (E

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (date of earliest event reported): November 5, 2025 EHEALTH, INC. (Exact Name of Registrant as Specified in its Charter) Delaware 001-33071 56-2357876 (State or other jurisdiction of incorporation) (Commission File Num

November 5, 2025 EX-99.1

eHealth, Inc. Announces Third Quarter 2025 Results Raises 2025 annual earnings guidance to reflect strong YTD performance Comments on strong start to the Annual Enrollment Period Completed extension of term loan maturity providing additional financia

eHealth, Inc. Announces Third Quarter 2025 Results Raises 2025 annual earnings guidance to reflect strong YTD performance Comments on strong start to the Annual Enrollment Period Completed extension of term loan maturity providing additional financial flexibility AUSTIN, Texas — November 5, 2025 — eHealth, Inc. (Nasdaq: EHTH), a leading private online health insurance marketplace, today announced

October 7, 2025 EX-99.1

eHealth Announces Extension of Blue Torch Term Loan eHealth Reaffirms its Commitment to Enhance Capital Structure Beyond this Deal

eHealth Announces Extension of Blue Torch Term Loan eHealth Reaffirms its Commitment to Enhance Capital Structure Beyond this Deal AUSTIN, Texas, October 7, 2025 – eHealth, Inc.

October 7, 2025 CORRESP

* * * * *

October 7, 2025 VIA EDGAR U.S. Securities and Exchange Commission Division of Corporation Finance Office of Finance 100 F Street, N.E. Washington, D.C. 20549 Attention: Jee Yeon Ahn and Michael Henderson Re: eHealth, Inc. Form 10-K for the Fiscal Year Ended December 31, 2024 Form 8-K filed August 6, 2025 File No. 001-33071 Dear Ladies and Gentlemen: eHealth, Inc. (the “Company,” “we,” “us” or “our

October 7, 2025 EX-10.1

THIRD AMENDMENT TO CREDIT AGREEMENT

EXECUTION VERSION THIRD AMENDMENT TO CREDIT AGREEMENT This THIRD AMENDMENT TO CREDIT AGREEMENT dated as of October 6, 2025 (this “Third Amendment”), is entered into among EHEALTH, INC.

October 7, 2025 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (date of earliest event reported): October 6, 2025 EHEALTH, INC. (Ex

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (date of earliest event reported): October 6, 2025 EHEALTH, INC. (Exact Name of Registrant as Specified in its Charter) Delaware 001-33071 56-2357876 (State or other jurisdiction of incorporation) (Commission File Numb

September 24, 2025 LETTER

LETTER

September 24, 2025 John Dolan Chief Financial Officer eHealth, Inc. 13620 Ranch Road 620 N, Suite A250 Austin, TX 78717 Re: eHealth, Inc. Form 10-K for Fiscal Year Ended December 31, 2024 Form 8-K filed August 6, 2025 File No. 001-33071 Dear John Dolan: We have limited our review of your filing to the financial statements and related disclosures and have the following comment. Please respond to th

September 19, 2025 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (date of earliest event reported): September 17, 2025 EHEALTH, INC.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (date of earliest event reported): September 17, 2025 EHEALTH, INC. (Exact Name of Registrant as Specified in its Charter) Delaware 001-33071 56-2357876 (State or other jurisdiction of incorporation) (Commission File N

August 13, 2025 CORRESP

[REMAINDER OF PAGE INTENTIONALLY LEFT BLANK]

August 13, 2025 Re: eHealth, Inc. Registration Statement on Form S-3 Filed August 7, 2025 File No. 333-289376 Via EDGAR U.S. Securities and Exchange Commission Division of Corporation Finance Office of Finance 100 F Street, NE Washington, DC 20549 Attention: Madeleine Joy Mateo Dear Ms. Joy Mateo: In accordance with Rule 461 under the Securities Act of 1933, as amended, the undersigned registrant

August 12, 2025 LETTER

LETTER

August 12, 2025 Francis Soistman Chief Executive Officer eHealth, Inc. 13620 Ranch Road 620 N. Suite A250 Austin, TX 78717 Re: eHealth, Inc. Registration Statement on Form S-3 Filed August 7, 2025 File No. 333-289376 Dear Francis Soistman: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for accele

August 7, 2025 EX-FILING FEES

Filing Fee Table

Exhibit 107 Calculation of Filing Fee Table Form S-8 (Form Type) eHealth, Inc. (Exact Name of Registrant as Specified in its Charter) Table 1: Newly Registered Securities Security Type Security Class Title Fee Calculation Rule Amount Registered (1) Proposed Maximum Offering Price Per Unit Maximum Aggregate Offering Price Fee Rate Amount of Registration Fee Equity Common Stock, par value $0.001 per

August 7, 2025 S-8

As filed with the Securities and Exchange Commission on August 7, 2025

As filed with the Securities and Exchange Commission on August 7, 2025 Registration No.

August 7, 2025 EX-FILING FEES

Filing Fee Table

Exhibit 107 CALCULATION OF FILING FEE TABLE FORM S-3 (Form Type) EHEALTH, INC. (Exact Name of Registrant as Specified in its Charter) Table 1: Carry Forward Securities Security Type Security Class Title Fee Calculation Rule or Carry Forward Rule Amount Registered Proposed Maximum Offering Price Per Unit Maximum Aggregate Offering Price Fee Rate Amount of Registration Fee Carry Forward Form Type Ca

August 7, 2025 EX-4.3

Form of Indenture

Exhibit 4.3 EHEALTH, INC. INDENTURE Dated as of , 20 [] Trustee TABLE OF CONTENTS Page ARTICLE I DEFINITIONS AND INCORPORATION BY REFERENCE 1 Section 1.1 Definitions 1 Section 1.2 Other Definitions 4 Section 1.3 Incorporation by Reference of Trust Indenture Act 4 Section 1.4 Rules of Construction 5 ARTICLE II THE SECURITIES 5 Section 2.1 Issuable in Series 5 Section 2.2 Establishment of Terms of S

August 7, 2025 S-3

As filed with the Securities and Exchange Commission on August 7, 2025

As filed with the Securities and Exchange Commission on August 7, 2025 Registration No.

August 7, 2025 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2025 ☐ TRANSITION REPORT PURSUANT TO S

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2025 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-33071 EHEALTH, INC. (Exact

August 6, 2025 EX-99.2

©2025 eHealthInsurance Services, Inc. Q2 2025 Financial Results 1 ©2025 eHealthInsurance Services, Inc. 2 Safe Harbor Statement Forward-Looking Statements This presentation includes forward-looking statements within the meaning of the federal securit

a2q25earningsslidesfinal ©2025 eHealthInsurance Services, Inc. Q2 2025 Financial Results 1 ©2025 eHealthInsurance Services, Inc. 2 Safe Harbor Statement Forward-Looking Statements This presentation includes forward-looking statements within the meaning of the federal securities laws. Forward-looking statements generally relate to future events or our future financial or operating performance. Forw

August 6, 2025 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (date of earliest event reported): August 6, 2025 EHEALTH, INC. (Exa

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (date of earliest event reported): August 6, 2025 EHEALTH, INC. (Exact Name of Registrant as Specified in its Charter) Delaware 001-33071 56-2357876 (State or other jurisdiction of incorporation) (Commission File Numbe

August 6, 2025 EX-99.1

eHealth, Inc. Announces Second Quarter 2025 Results Q2 2025 results reflect strategic execution in a rapidly evolving industry Raises 2025 annual revenue and earnings guidance to reflect strong YTD performance

eHealth, Inc. Announces Second Quarter 2025 Results Q2 2025 results reflect strategic execution in a rapidly evolving industry Raises 2025 annual revenue and earnings guidance to reflect strong YTD performance AUSTIN, Texas — August 6, 2025 — eHealth, Inc. (Nasdaq: EHTH), a leading private online health insurance marketplace, today announced its financial results for the second quarter ended June

July 29, 2025 EX-10.2

CEO Severance Agreement between eHealth, Inc. and Derrick Duke

EHEALTH, INC. SEVERANCE AGREEMENT THIS SEVERANCE AGREEMENT (the “Agreement”) is entered into effective as of August 4, 2025 (the “Effective Date”) by and between eHealth, Inc. (together with its subsidiaries, the “Company”) and Derrick Duke (“Executive”). 1.At-Will Employment. Executive and the Company agree that Executive’s employment with the Company constitutes “at-will” employment. Executive a

July 29, 2025 EX-10.1

Offer Letter between eHealthInsurance Services, Inc. and Derrick Duke, dated July 28, 2025

July 28, 2025 Derrick Duke [*****] [*****] Dear Derrick, Join us in creating a better way for all, here at eHealthInsurance Services, Inc.

July 29, 2025 EX-99.1

eHealth Announces CEO Succession Derrick Duke Appointed Chief Executive Officer After Transition Period Fran Soistman to Retire, Remain on eHealth Board of Directors

eHealth Announces CEO Succession Derrick Duke Appointed Chief Executive Officer After Transition Period Fran Soistman to Retire, Remain on eHealth Board of Directors AUSTIN, Texas, July 29, 2025 – eHealth, Inc.

July 29, 2025 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (date of earliest event reported): July 28, 2025 EHEALTH, INC. (Exac

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (date of earliest event reported): July 28, 2025 EHEALTH, INC. (Exact Name of Registrant as Specified in its Charter) Delaware 001-33071 56-2357876 (State or other jurisdiction of incorporation) (Commission File Number

June 24, 2025 8-K

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits, Submission of Matters to a Vote of Security Holders

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (date of earliest event reported): June 18, 2025 EHEALTH, INC. (Exact Name of Registrant as Specified in its Charter) Delaware 001-33071 56-2357876 (State or other jurisdiction of incorporation) (Commission File Number

June 24, 2025 EX-10.2

Amended and Restated 2024 Equity Incentive Plan

EHEALTH, INC. AMENDED AND RESTATED 2024 EQUITY INCENTIVE PLAN 1.Purposes of the Plan. The purposes of this Plan are: •to attract and retain the best available personnel for positions of substantial responsibility, •to provide additional incentive to Employees, Directors and Consultants, and •to promote the success of the Company’s business. The Plan permits the grant of Incentive Stock Options, No

June 24, 2025 EX-10.1

CEO Transition Letter Agreement

June 18, 2025 Dear Fran: This letter confirms our discussion concerning your agreement to continue your service as the Chief Executive Officer of eHealth, Inc.

June 2, 2025 DEFA14A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a party other than the Registrant ☐

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, For Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☐ Definitive Proxy State

May 7, 2025 8-K

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (date of earliest event reported): May 7, 2025 EHEALTH, INC. (Exact Name of Registrant as Specified in its Charter) Delaware 001-33071 56-2357876 (State or other jurisdiction of incorporation) (Commission File Number)

May 7, 2025 EX-99.1

eHealth, Inc. Announces First Quarter 2025 Results Strong first quarter results with 22% total revenue growth YoY 25% growth in Medicare Advantage submissions YoY Growth accompanied by Medicare unit margin expansion YoY

eHealth, Inc. Announces First Quarter 2025 Results Strong first quarter results with 22% total revenue growth YoY 25% growth in Medicare Advantage submissions YoY Growth accompanied by Medicare unit margin expansion YoY AUSTIN, Texas — May 7, 2025 — eHealth, Inc. (Nasdaq: EHTH), a leading private online health insurance marketplace, today announced its financial results for the first quarter ended

May 7, 2025 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2025 ☐ TRANSITION REPORT PURSUANT TO

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2025 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-33071 EHEALTH, INC. (Exact

May 7, 2025 EX-99.2

©2025 eHealthInsurance Services, Inc. Q1 2025 Financial Results 1 ©2025 eHealthInsurance Services, Inc. 2 Safe Harbor Statement Forward-Looking Statements This presentation includes forward-looking statements within the meaning of the federal securit

©2025 eHealthInsurance Services, Inc. Q1 2025 Financial Results 1 ©2025 eHealthInsurance Services, Inc. 2 Safe Harbor Statement Forward-Looking Statements This presentation includes forward-looking statements within the meaning of the federal securities laws. Forward-looking statements generally relate to future events or our future financial or operating performance. Forward-looking statements in

April 28, 2025 DEF 14A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a party other than the Registrant ☐

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, For Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☒ Definitive Proxy State

April 28, 2025 DEFA14A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a party other than the Registrant ☐

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, For Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☐ Definitive Proxy State

April 28, 2025 ARS

ARS

eHealth, Inc. • Fremont, CA; Salt Lake City, UT; Austin, TX; Indianapolis, IN • www.ehealth.com Dear Fellow Stockholders, $VΖUHȵHFWRQWKHMRXUQH\RIH+HDOWKRYHUWKHSDVW\HDUΖDP ȴOOHGZLWKLPPHQVHSULGHLQZKDW our organization has accomplished and excitement about the path ahead. In an industry marked by continuous change and growing complexity, eHealth has not only adapted but WKULYHG

February 27, 2025 EX-19

Insider Trading Policy

EHEALTH, INC. INSIDER TRADING POLICY (As Amended on December 11, 2024) A.POLICY OVERVIEW eHealth, Inc. (together with any subsidiaries, collectively the “Company”) has adopted this Insider Trading Policy (the “Policy”) to help you comply with the federal and state securities laws and regulations that govern trading in securities and to help the Company minimize its own legal and reputational risk.

February 27, 2025 EX-10.9

, 2024, between Michelle Barbeau and eHealth, Inc.

EHEALTH, INC. SEVERANCE AGREEMENT THIS SEVERANCE AGREEMENT (the “Agreement”) is entered into effective as of January 1, 2024 by and between EHEALTH, INC. (together with its subsidiary, eHealthInsurance Services, Inc., the “Company”) and Michelle Barbeau (“Executive”). 1. AT-WILL EMPLOYMENT. Executive and the Company agree that Executive’s employment with Company constitutes “at-will” employment. E

February 27, 2025 10-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2024 ☐ TRANSITION REPORT PURSUANT TO SECTI

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-33071 EHEALTH, INC. (Exact name

February 26, 2025 EX-99.2

©2025 eHealthInsurance Services, Inc. Q4 & FY 2024 Financial Results 1 ©2025 eHealthInsurance Services, Inc. 2 Safe Harbor Statement Forward-Looking Statements This presentation includes forward-looking statements within the meaning of the federal se

©2025 eHealthInsurance Services, Inc. Q4 & FY 2024 Financial Results 1 ©2025 eHealthInsurance Services, Inc. 2 Safe Harbor Statement Forward-Looking Statements This presentation includes forward-looking statements within the meaning of the federal securities laws. Forward-looking statements generally relate to future events or our future financial or operating performance. Forward-looking statemen

February 26, 2025 8-K

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (date of earliest event reported): February 26, 2025 EHEALTH, INC. (Exact Name of Registrant as Specified in its Charter) Delaware 001-33071 56-2357876 (State or other jurisdiction of incorporation) (Commission File Nu

February 26, 2025 EX-99.1

eHealth, Inc. Announces Fourth Quarter and Fiscal Year 2024 Results Reports record-high total revenue and net income quarter in Company’s history Outperforms FY’24 revenue and profitability guidance driven by 42% growth in Medicare Advantage submissi

eHealth, Inc. Announces Fourth Quarter and Fiscal Year 2024 Results Reports record-high total revenue and net income quarter in Company’s history Outperforms FY’24 revenue and profitability guidance driven by 42% growth in Medicare Advantage submissions and 16% Medicare unit margin expansion in fourth quarter Ends FY’24 with highest ever commissions receivable balance of $1.0 billion AUSTIN, Texas

February 14, 2025 EX-1

JOINT FILING AGREEMENT

EX-1 2 ex-1.htm JOINT FILING AGREEMENT EXHIBIT A JOINT FILING AGREEMENT The undersigned hereby agree that the statement on Schedule 13G with respect to the common stock of eHealth, Inc., dated as of February 14, 2025 is, and any amendments thereto (including amendments on Schedule 13D) signed by each of the undersigned shall be, filed on behalf of each of us pursuant to and in accordance with the

December 17, 2024 EX-99.1

eHealth, Inc. Updates Guidance for Fiscal Year 2024 Following Strong AEP Performance

PRESS RELEASE eHealth, Inc. Updates Guidance for Fiscal Year 2024 Following Strong AEP Performance AUSTIN, Texas, December 17, 2024 — eHealth, Inc. (Nasdaq: EHTH), a leading private online health insurance marketplace, today provided commentary on its Annual Enrollment Period (AEP) performance and updated guidance ranges for the fiscal year ending December 31, 2024. “This dynamic enrollment period

December 17, 2024 8-K

Regulation FD Disclosure, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (date of earliest event reported): December 17, 2024 EHEALTH, INC. (Exact Name of Registrant as Specified in its Charter) Delaware 001-33071 56-2357876 (State or other jurisdiction of incorporation) (Commission File Nu

November 14, 2024 SC 13G/A

EHTH / eHealth, Inc. / FIN Capital Partners LP - AMENDMENT NO. 1 TO THE SCHEDULE 13G Passive Investment

SC 13G/A 1 sc13ga113982ehth11142024.htm AMENDMENT NO. 1 TO THE SCHEDULE 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G (Rule 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULES 13d-1(b), (c), AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2(b) (Amendment No. 1)1 eHealth, Inc. (Name of Issuer) Common Stock, par value $0.001

November 12, 2024 SC 13G/A

EHTH / eHealth, Inc. / VANGUARD GROUP INC Passive Investment

SC 13G/A 1 UnitedStates13GeHealthInc.txt 240.13d-102 Schedule 13G - Information to be included in statements filed pursuant to 240.13d-1(b), (c), and (d) and amendments thereto filed pursuant to 240.13d-2. Securities and Exchange Commission, Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No. 2)* (Name of Issuer) eHealth Inc (Title of Class of Securities) C

November 6, 2024 8-K

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (date of earliest event reported): November 6, 2024 EHEALTH, INC. (Exact Name of Registrant as Specified in its Charter) Delaware 001-33071 56-2357876 (State or other jurisdiction of incorporation) (Commission File Num

November 6, 2024 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2024 ☐ TRANSITION REPORT PURSUANT

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-33071 EHEALTH, INC. (E

November 6, 2024 EX-99.1

eHealth, Inc. Announces Third Quarter 2024 Results Third quarter performance driven by strong Medicare segment execution YoY Entered AEP on solid financial and operational foundation Completed extension of term loan at improved interest rate terms

eHealth, Inc. Announces Third Quarter 2024 Results Third quarter performance driven by strong Medicare segment execution YoY Entered AEP on solid financial and operational foundation Completed extension of term loan at improved interest rate terms AUSTIN, Texas — November 6, 2024 — eHealth, Inc. (Nasdaq: EHTH), a leading private online health insurance marketplace, today announced its financial re

November 6, 2024 EX-99.2

©2024 eHealthInsurance Services, Inc. Q3 2024 Financial Results 1 ©2024 eHealthInsurance Services, Inc. 2 Safe Harbor Statement Forward-Looking Statements This presentation includes forward-looking statements within the meaning of the federal securit

©2024 eHealthInsurance Services, Inc. Q3 2024 Financial Results 1 ©2024 eHealthInsurance Services, Inc. 2 Safe Harbor Statement Forward-Looking Statements This presentation includes forward-looking statements within the meaning of the federal securities laws. Forward-looking statements generally relate to future events or our future financial or operating performance. Forward-looking statements in

November 6, 2024 EX-10.1

Severance Agreement, dated August 31, 2024, between John Dolan and e

EHEALTH, INC. SEVERANCE AGREEMENT THIS SEVERANCE AGREEMENT (the “Agreement”) is entered into effective as of August 31, 2024 (the (“Effective Date”) by and between eHealth, Inc. (together with its subsidiaries, the “Company”) and John J. Dolan (“Executive”). 1. AT-WILL EMPLOYMENT. Executive and the Company agree that Executive’s employment with Company constitutes “at-will” employment. Executive a

November 4, 2024 SC 13G/A

EHTH / eHealth, Inc. / VANGUARD GROUP INC Passive Investment

SC 13G/A 1 UnitedStates13GeHealthInc.txt 240.13d-102 Schedule 13G - Information to be included in statements filed pursuant to 240.13d-1(b), (c), and (d) and amendments thereto filed pursuant to 240.13d-2. Securities and Exchange Commission, Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No. 1)* (Name of Issuer) eHealth Inc (Title of Class of Securities) C

November 1, 2024 8-K

Entry into a Material Definitive Agreement, Financial Statements and Exhibits, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (date of earliest event reported): November 1, 2024 EHEALTH, INC. (Exact Name of Registrant as Specified in its Charter) Delaware 001-33071 56-2357876 (State or other jurisdiction of incorporation) (Commission File Num

November 1, 2024 EX-10.1

2024, by and among eHealth, Inc., Blue Torch Finance LLC and the lenders identified therein

Execution Version SECOND AMENDMENT TO CREDIT AGREEMENT This SECOND AMENDMENT TO CREDIT AGREEMENT dated as of November 1, 2024 (this “Second Amendment”), is entered into among EHEALTH, INC.

October 9, 2024 8-K

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (date of earliest event reported): October 3, 2024 EHEALTH, INC. (Exact Name of Registrant as Specified in its Charter) Delaware 001-33071 56-2357876 (State or other jurisdiction of incorporation) (Commission File Numb

September 24, 2024 EX-99.1

eHealth Appoints Prama Bhatt to Board of Directors

PRESS RELEASE eHealth Appoints Prama Bhatt to Board of Directors AUSTIN, Texas – September 24, 2024 – eHealth, Inc.

September 24, 2024 8-K

Regulation FD Disclosure, Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (date of earliest event reported): September 21, 2024 EHEALTH, INC. (Exact Name of Registrant as Specified in its Charter) Delaware 001-33071 56-2357876 (State or other jurisdiction of incorporation) (Commission File N

August 7, 2024 8-K

Regulation FD Disclosure, Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (date of earliest event reported): August 6, 2024 EHEALTH, INC. (Exact Name of Registrant as Specified in its Charter) Delaware 001-33071 56-2357876 (State or other jurisdiction of incorporation) (Commission File Numbe

August 7, 2024 EX-99.1

eHealth, Inc. Announces Second Quarter 2024 Results Strong second quarter results driven by Medicare segment growth YoY Raises 2024 Annual Guidance

eHealth, Inc. Announces Second Quarter 2024 Results Strong second quarter results driven by Medicare segment growth YoY Raises 2024 Annual Guidance AUSTIN, Texas — August 7, 2024 — eHealth, Inc. (Nasdaq: EHTH), a leading private online health insurance marketplace, today announced its financial results for the second quarter ended June 30, 2024. CEO Comments “eHealth delivered another quarter of s

August 7, 2024 EX-99.3

Form of Notice of Time-Based Restricted Stock Unit Grant and Restricted Stock Unit Agreement under the 2024 Equity Incentive Plan

EHEALTH, INC. 2024 EQUITY INCENTIVE PLAN RESTRICTED STOCK UNIT AGREEMENT NOTICE OF RESTRICTED STOCK UNIT GRANT Unless otherwise defined herein, the terms defined in the eHealth, Inc. 2024 Equity Incentive Plan (the “Plan”) will have the same defined meanings in this Restricted Stock Unit Agreement which includes the Notice of Restricted Stock Unit Grant (the “Notice of Grant”), the Terms and Condi

August 7, 2024 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2024 ☐ TRANSITION REPORT PURSUANT TO S

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-33071 EHEALTH, INC. (Exact

August 7, 2024 EX-FILING FEES

Filing Fee Table

Exhibit 107 Calculation of Filing Fee Table Form S-8 (Form Type) eHealth, Inc. (Exact Name of Registrant as Specified in its Charter) Table 1: Newly Registered Securities Security Type Security Class Title Fee Calculation Rule Amount Registered (1) Proposed Maximum Offering Price Per Unit Maximum Aggregate Offering Price Fee Rate Amount of Registration Fee Equity Common Stock, par value $0.001 per

August 7, 2024 EX-10.1

Independent Contractor Agreement, dated May 29, 2024 between John Stelben and eHealthInsurance Services, Inc.

eHealthInsurance Services, Inc. INDEPENDENT CONTRACTOR AGREEMENT This Independent Contractor Agreement (“Agreement”) is made effective as of May 29, 2024 (“Effective Date”) by and between eHealthInsurance Services, Inc., a Delaware Corporation having its principal office located at 13620 Ranch Rd 620 N, Suite A250, Austin, TX 78717 and its subsidiaries, affiliates, successors or assigns (together

August 7, 2024 EX-99.3

eHealth, Inc. Announces 2025 CEO Succession Plan Fran Soistman to Retire as CEO in early 2025, Will Remain on Board of Directors eHealth Board Commences Search for Next CEO

PRESS RELEASE eHealth, Inc. Announces 2025 CEO Succession Plan Fran Soistman to Retire as CEO in early 2025, Will Remain on Board of Directors eHealth Board Commences Search for Next CEO Austin, Texas – August 6, 2024 – eHealth, Inc. (Nasdaq: EHTH), a leading private online health insurance marketplace (the "Company"), today announced that Fran Soistman will retire from his role as Chief Executive

August 7, 2024 EX-99.2

©2024 eHealthInsurance Services, Inc. Q2 2024 Financial Results 1 ©2024 eHealthInsurance Services, Inc. 2 Safe Harbor Statement Forward-Looking Statements This presentation includes forward-looking statements within the meaning of the federal securit

©2024 eHealthInsurance Services, Inc. Q2 2024 Financial Results 1 ©2024 eHealthInsurance Services, Inc. 2 Safe Harbor Statement Forward-Looking Statements This presentation includes forward-looking statements within the meaning of the federal securities laws. Forward-looking statements generally relate to future events or our future financial or operating performance. Forward-looking statements in

August 7, 2024 EX-99.4

Equity Incentive Plan

EHEALTH, INC. 2024 EQUITY INCENTIVE PLAN PERFORMANCE-BASED RESTRICTED STOCK UNIT AGREEMENT NOTICE OF RESTRICTED STOCK UNIT GRANT Unless otherwise defined herein, the terms defined in the eHealth, Inc. 2024 Equity Incentive Plan (the “Plan”) will have the same defined meanings in this Performance-Based Restricted Stock Unit Agreement which includes the Notice of Performance-Based Restricted Stock U

August 7, 2024 S-8

As filed with the Securities and Exchange Commission on August 7, 2024

As filed with the Securities and Exchange Commission on August 7, 2024 Registration No.

August 7, 2024 EX-99.2

Form of Notice of Stock Option Grant and Stock Option Agreement under the

◦ EHEALTH, INC. 2024 EQUITY INCENTIVE PLAN STOCK OPTION AGREEMENT NOTICE OF STOCK OPTION GRANT Unless otherwise defined herein, the terms defined in the eHealth, Inc. 2024 Equity Incentive Plan (the “Plan”) shall have the same defined meanings in this Stock Option Agreement, which includes the Notice of Stock Option Grant (the “Notice of Grant”), the Terms and Conditions of Stock Option Grant, att

July 8, 2024 SC 13G/A

EHTH / eHealth, Inc. / BlackRock Inc. Passive Investment

SC 13G/A 1 us28238p1093070824.txt us28238p1093070824.txt SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No: 5) eHealth, Inc. - (Name of Issuer) Common Stock - (Title of Class of Securities) 28238P109 - (CUSIP Number) June 30, 2024 - (Date of Event Which Requires Filing of this Statement) Check the appropriate box to desig

June 14, 2024 EX-10.2

Amended and Restated 2020 Employee Stock Purchase Plan

eHealth, Inc. Amended and Restated 2020 Employee Stock Purchase Plan Approved by the Board of Directors: April 25, 2024 Approved by the Stockholders: June 12, 2024 1.General; Purpose. (a)The Plan provides a means by which Eligible Employees of the Company and certain designated Related Corporations may be given an opportunity to purchase shares of Common Stock. The Plan permits the Company to gran

June 14, 2024 8-K

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits, Submission of Matters to a Vote of Security Holders

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (date of earliest event reported): June 12, 2024 EHEALTH, INC. (Exact Name of Registrant as Specified in its Charter) Delaware 001-33071 56-2357876 (State or other jurisdiction of incorporation) (Commission File Number

June 14, 2024 EX-10.1

2024 Equity Incentive Plan

EHEALTH, INC. 2024 EQUITY INCENTIVE PLAN Approved by the Board of Directors: April 25, 2024 Approved by the Stockholders: June 12, 2024 1.Purposes of the Plan. The purposes of this Plan are: •to attract and retain the best available personnel for positions of substantial responsibility, •to provide additional incentive to Employees, Directors and Consultants, and •to promote the success of the Com

June 10, 2024 DEFA14A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a party other than the Registrant ☐

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, For Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☐ Definitive Proxy State

May 30, 2024 EX-99.1

eHealth Chief Financial Officer John Stelben to Retire in August eHealth’s Chief Accounting Officer John Dolan to be Named Chief Financial Officer

PRESS RELEASE eHealth Chief Financial Officer John Stelben to Retire in August eHealth’s Chief Accounting Officer John Dolan to be Named Chief Financial Officer AUSTIN, TX – May 30, 2024 – eHealth, Inc.

May 30, 2024 8-K

Regulation FD Disclosure, Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (date of earliest event reported): May 29, 2024 EHEALTH, INC. (Exact Name of Registrant as Specified in its Charter) Delaware 001-33071 56-2357876 (State or other jurisdiction of incorporation) (Commission File Number)

May 23, 2024 DEFA14A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a party other than the Registrant ☐

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, For Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☐ Definitive Proxy State

May 7, 2024 8-K

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (date of earliest event reported): May 7, 2024 EHEALTH, INC. (Exact Name of Registrant as Specified in its Charter) Delaware 001-33071 56-2357876 (State or other jurisdiction of incorporation) (Commission File Number)

May 7, 2024 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2024 ☐ TRANSITION REPORT PURSUANT TO

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-33071 EHEALTH, INC. (Exact

May 7, 2024 EX-99.1

eHealth, Inc. Announces First Quarter 2024 Results Strong first quarter results with total revenue growth of 26% YoY Significant YoY improvement in profitability metrics and operating cash flow

eHealth, Inc. Announces First Quarter 2024 Results Strong first quarter results with total revenue growth of 26% YoY Significant YoY improvement in profitability metrics and operating cash flow AUSTIN, Texas — May 7, 2024 — eHealth, Inc. (Nasdaq: EHTH), a leading private online health insurance marketplace, today announced its financial results for the first quarter ended March 31, 2024. CEO Comme

May 7, 2024 EX-99.2

©2024 eHealthInsurance Services, Inc. Q1 2024 Financial Results 1 ©2024 eHealthInsurance Services, Inc. 2 Safe Harbor Statement Forward-Looking Statements This presentation includes forward-looking statements within the meaning of the federal securit

©2024 eHealthInsurance Services, Inc. Q1 2024 Financial Results 1 ©2024 eHealthInsurance Services, Inc. 2 Safe Harbor Statement Forward-Looking Statements This presentation includes forward-looking statements within the meaning of the federal securities laws. Forward-looking statements generally relate to future events or our future financial or operating performance. Forward-looking statements in

April 26, 2024 ARS

ARS

eHealth, Inc. • Salt Lake City, UT; Austin, TX; Indianapolis, IN • www.ehealth.com Dear Fellow Stockholders, In 2023, eHealth continued to deliver a world-class experience to our customers while making significant strides toward our goal of sustainable profitable growth and positive operating cash flow generation. Last year marked the completion of our business transformation program, which launch

April 26, 2024 DEFA14A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a party other than the Registrant ☐

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, For Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☐ Definitive Proxy State

April 26, 2024 DEF 14A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a party other than the Registrant ☐

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, For Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☒ Definitive Proxy State

February 29, 2024 10-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 ☐ TRANSITION REPORT PURSUANT TO SECTI

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-33071 EHEALTH, INC. (Exact name

February 29, 2024 EX-97

Recovery Policy

EHEALTH, INC. COMPENSATION RECOVERY POLICY As adopted on September 28, 2023 eHealth, Inc. (the “Company”) is committed to strong corporate governance. As part of this commitment, the Company’s Board of Directors (the “Board”) has adopted this Compensation Recovery Policy (the “Policy”). The Policy is intended to further the Company’s pay-for-performance philosophy and to comply with applicable law

February 27, 2024 EX-99.2

©2024 eHealthInsurance Services, Inc. Q4 & FY 2023 Financial Results 1 ©2024 eHealthInsurance Services, Inc. 2 Safe Harbor Statement Forward-Looking Statements This presentation includes forward-looking statements within the meaning of the federal se

©2024 eHealthInsurance Services, Inc. Q4 & FY 2023 Financial Results 1 ©2024 eHealthInsurance Services, Inc. 2 Safe Harbor Statement Forward-Looking Statements This presentation includes forward-looking statements within the meaning of the federal securities laws. Forward-looking statements generally relate to future events or our future financial or operating performance. Forward-looking statemen

February 27, 2024 EX-99.1

eHealth, Inc. Announces Fourth Quarter and Fiscal Year 2023 Results Fourth quarter revenue growth of 26% YoY driven by strong and profitable Medicare enrollment growth

eHealth, Inc. Announces Fourth Quarter and Fiscal Year 2023 Results Fourth quarter revenue growth of 26% YoY driven by strong and profitable Medicare enrollment growth AUSTIN, Texas — February 27, 2024 — eHealth, Inc. (Nasdaq: EHTH), a leading private online health insurance marketplace, today announced its financial results for the fourth quarter and fiscal year ended December 31, 2023. CEO Comme

February 27, 2024 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (date of earliest event reported): February 27, 2024 EHEALTH, INC. (

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (date of earliest event reported): February 27, 2024 EHEALTH, INC. (Exact Name of Registrant as Specified in its Charter) Delaware 001-33071 56-2357876 (State or other jurisdiction of incorporation) (Commission File Nu

February 14, 2024 EX-99.A

Exhibit A

EX-99.A 2 exa.htm A JOING FILING AGREEMENT 8 Knots Management, LLC SC 13GA CUSIP No. 28238P109 13G Page 11 of 11 EXHIBIT A JOINT FILING AGREEMENT The undersigned hereby agree that the statement on Schedule 13G with respect to the common stock of eHealth, Inc., dated as of February 14, 2024 is, and any amendments thereto (including amendments on Schedule 13D) signed by each of the undersigned shall

February 14, 2024 SC 13G/A

EHTH / eHealth, Inc. / Palo Alto Investors LP Passive Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULE 13d-1(b), (c), AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2(b) (AMENDMENT NO. 3)* eHealth, Inc. (Name of Issuer) Common Stock (Title of Class of Securities) 28238P109 (CUSIP Number) December 31, 2023 (Date of Event which Requires Filing

February 14, 2024 SC 13G/A

EHTH / eHealth, Inc. / 8 KNOTS MANAGEMENT, LLC - AMENDMENT NO. 1 Passive Investment

SC 13G/A 1 ehth-sc13ga123123.htm AMENDMENT NO. 1 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1)* eHealth, Inc. (Name of Issuer) Common Stock, par value $0.001 per share (Title of Class of Securities) 28238P109 (CUSIP Number) December 31, 2023 (Date of Event Which Requires Filing of This Statement) Check

February 13, 2024 SC 13G

EHTH / eHealth, Inc. / VANGUARD GROUP INC - SCHEDULE 13G Passive Investment

SC 13G 1 tv0820-ehealthinc.htm SCHEDULE 13G SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 Name of issuer: eHealth Inc Title of Class of Securities: Common Stock CUSIP Number: 28238P109 Date of Event Which Requires Filing of this Statement: December 29, 2023 Check the appropriate box to designate the rule pursuant to which this Sche

February 7, 2024 SC 13G/A

EHTH / eHealth, Inc. / GOLDMAN SACHS GROUP INC Passive Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1)* EHEALTH, INC. - (Name of Issuer) Common Stock, par value $0.001 per share - (Title of Class of Securities) 28238P109 - (CUSIP Number) December 29, 2023 - (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the r

January 26, 2024 8-K

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (date of earliest event reported): January 26, 2024 EHEALTH, INC. (Exact Name of Registrant as Specified in its Charter) Delaware 001-33071 56-2357876 (State or other jurisdiction of incorporation) (Commission File Num

January 26, 2024 EX-99.1

eHealth, Inc. Announces Preliminary Results for the Fourth Quarter and Fiscal Year 2023

PRESS RELEASE eHealth, Inc. Announces Preliminary Results for the Fourth Quarter and Fiscal Year 2023 AUSTIN, Texas, January 26, 2024 — eHealth, Inc. (Nasdaq: EHTH), a leading private online health insurance marketplace, today announced preliminary, unaudited financial results and select operating metrics for the fourth quarter and fiscal year ended December 31, 2023. “Our Annual Enrollment Period

January 25, 2024 SC 13G/A

EHTH / eHealth, Inc. / MILLENNIUM MANAGEMENT LLC Passive Investment

SC 13G/A 1 EHTHSC13GA2.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (AMENDMENT NO. 2) EHEALTH, INC. (Name of Issuer) COMMON STOCK, PAR VALUE $0.001 PER SHARE (Title of Class of Securities) 28238P109 (CUSIP Number) DECEMBER 31, 2023 (Date of event which requires filing of this statement) Check the appropriate box

January 24, 2024 SC 13G/A

EHTH / eHealth, Inc. / BlackRock Inc. Passive Investment

SC 13G/A 1 us28238p1093012424.txt us28238p1093012424.txt SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No: 4) eHealth, Inc. - (Name of Issuer) Common Stock - (Title of Class of Securities) 28238P109 - (CUSIP Number) December 31, 2023 - (Date of Event Which Requires Filing of this Statement) Check the appropriate box to d

December 19, 2023 SC 13G

EHTH / eHealth, Inc. / FIN Capital Partners LP - SCHEDULE 13G Passive Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G (Rule 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULES 13d-1(b), (c), AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2(b) (Amendment No. )1 eHealth, Inc. (Name of Issuer) Common Stock, par value $0.001 per share (Title of Class of Securities) 28238P109 (CUSIP Number) November 8,

December 19, 2023 EX-99.1

Joint Filing Agreement

EX-99.1 2 ex991to13g13982ehth12192023.htm JOINT FILING AGREEMENT Exhibit 99.1 Joint Filing Agreement The undersigned hereby agree that the Statement on Schedule 13G dated December 19, 2023 with respect to the Common Stock, par value $0.001 per share, of eHealth, Inc., and any amendments thereto executed by each and any of the undersigned shall be filed on behalf of each of the undersigned pursuant

November 20, 2023 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (date of earliest event reported): November 20, 2023 EHEALTH, INC. (

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (date of earliest event reported): November 20, 2023 EHEALTH, INC. (Exact Name of Registrant as Specified in its Charter) Delaware 001-33071 56-2357876 (State or other jurisdiction of incorporation) (Commission File Nu

November 20, 2023 EX-99.1

eHealth, Inc. Announces Senior Leadership Changes and Reaffirms Full Year Fiscal 2023 Guidance

PRESS RELEASE eHealth, Inc. Announces Senior Leadership Changes and Reaffirms Full Year Fiscal 2023 Guidance SANTA CLARA, CA – November 20, 2023 – eHealth, Inc. (Nasdaq: EHTH) (eHealth.com), a leading online private health insurance marketplace, today announced senior leadership changes and reaffirmed guidance for the fiscal year ending December 31, 2023. Chief Operating Officer and Chief Transfor

November 9, 2023 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2023 ☐ TRANSITION REPORT PURSUANT

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-33071 EHEALTH, INC. (E

November 8, 2023 EX-99.2

©2023 eHealthInsurance Services, Inc. Q3 2023 Financial Results 1 ©2023 eHealthInsurance Services, Inc. 2 Safe Harbor Statement Forward-Looking Statements This presentation includes forward-looking statements within the meaning of the federal securit

©2023 eHealthInsurance Services, Inc. Q3 2023 Financial Results 1 ©2023 eHealthInsurance Services, Inc. 2 Safe Harbor Statement Forward-Looking Statements This presentation includes forward-looking statements within the meaning of the federal securities laws. Forward-looking statements generally relate to future events or our future financial or operating performance. Forward-looking statements in

November 8, 2023 8-K

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (date of earliest event reported): November 8, 2023 EHEALTH, INC. (Exact Name of Registrant as Specified in its Charter) Delaware 001-33071 56-2357876 (State or other jurisdiction of incorporation) (Commission File Num

November 8, 2023 EX-99.1

eHealth, Inc. Announces Third Quarter 2023 Results Entered AEP on strong financial and operational foundation

eHealth, Inc. Announces Third Quarter 2023 Results Entered AEP on strong financial and operational foundation SANTA CLARA, California — November 8, 2023 — eHealth, Inc. (Nasdaq: EHTH), a leading private online health insurance marketplace, today announced its financial results for the third quarter ended September 30, 2023. CEO Comments “eHealth delivered solid Q3 results reflecting favorable memb

August 8, 2023 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (date of earliest event reported): August 8, 2023 EHEALTH, INC. (Exa

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (date of earliest event reported): August 8, 2023 EHEALTH, INC. (Exact Name of Registrant as Specified in its Charter) Delaware 001-33071 56-2357876 (State or other jurisdiction of incorporation) (Commission File Numbe

August 8, 2023 EX-10.2

Form of Notice of Stock Unit Grant and Stock Unit Agreement (Annual Director Grant) under the Amended and Restated 2014 Equity Incentive Plan

eHealth, Inc. Amended and Restated 2014 Equity Incentive Plan Notice of Annual Outside Director Stock Unit Grant You have been granted the following Stock Unit award covering shares of the Common Stock of eHealth, Inc. (the “Company”). Each Stock Unit is equivalent to one share of Common Stock of the Company (a “Share”) for purposes of determining the number of Shares subject to this Stock Unit aw

August 8, 2023 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2023 ☐ TRANSITION REPORT PURSUANT TO S

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-33071 EHEALTH, INC. (Exact

August 8, 2023 EX-10.1

Form of Notice of Stock Unit Grant and Stock Unit Agreement (Initial Director Grant) under the

eHealth, Inc. Amended and Restated 2014 Equity Incentive Plan Notice of Initial Outside Director Stock Unit Grant You have been granted the following Stock Unit award covering shares of the Common Stock of eHealth, Inc. (the “Company”). Each Stock Unit is equivalent to one share of Common Stock of the Company (a “Share”) for purposes of determining the number of Shares subject to this Stock Unit a

August 8, 2023 EX-99.1

eHealth, Inc. Announces Second Quarter 2023 Results Strong second quarter results; 2023 guidance increased

eHealth, Inc. Announces Second Quarter 2023 Results Strong second quarter results; 2023 guidance increased SANTA CLARA, California — August 8, 2023 — eHealth, Inc. (Nasdaq: EHTH), a leading private online health insurance marketplace, today announced its financial results for the second quarter ended June 30, 2023. CEO Comments "eHealth delivered strong second quarter results with revenue and prof

August 8, 2023 EX-99.2

Q2 2023 Financial Results 2023 Copyright eHealth Insurance. Conference Call Slides 1 Safe Harbor Statement Forward-Looking Statements This presentation includes forward-looking statements within the meaning of the federal securities laws. Forward-loo

q22023earningsslidesfina Q2 2023 Financial Results 2023 Copyright eHealth Insurance.

July 10, 2023 SC 13D/A

EHTH / eHealth Inc / H.I.G.-GPII, Inc. - SC 13D/A Activist Investment

SC 13D/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 1)* EHEALTH, INC. (Name of Issuer) Common Stock, par value $0.001 per share (Title of Class of Securities) 28238P109 (CUSIP Number) c/o H.I.G. Capital, LLC 1450 Brickell Avenue, 31st Floor Miami, FL 33131 Attention: Richard H. Siegel, Esq. with a co

June 21, 2023 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (date of earliest event reported): June 14, 2023 EHEALTH, INC. (Exac

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (date of earliest event reported): June 14, 2023 EHEALTH, INC. (Exact Name of Registrant as Specified in its Charter) Delaware 001-33071 56-2357876 (State or other jurisdiction of incorporation) (Commission File Number

May 9, 2023 EX-99.1

eHealth, Inc. Announces First Quarter 2023 Results Strong first quarter performance reflects positive impact of ongoing transformation plan Continued positive trends in unit economics drive YoY Q1 profitability improvement $12.9M improvement in net l

eHealth, Inc. Announces First Quarter 2023 Results Strong first quarter performance reflects positive impact of ongoing transformation plan Continued positive trends in unit economics drive YoY Q1 profitability improvement $12.9M improvement in net loss and $12.2M improvement in adjusted EBITDA YoY 29% increase in cash flow from operations YoY SANTA CLARA, California — May 9, 2023 — eHealth, Inc.

May 9, 2023 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2023 ☐ TRANSITION REPORT PURSUANT TO

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-33071 EHEALTH, INC. (Exact

May 9, 2023 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (date of earliest event reported): May 9, 2023 EHEALTH, INC. (Exact

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (date of earliest event reported): May 9, 2023 EHEALTH, INC. (Exact Name of Registrant as Specified in its Charter) Delaware 001-33071 56-2357876 (State or other jurisdiction of incorporation) (Commission File Number)

May 9, 2023 EX-99.2

Q1 2023 Financial Results 2023 Copyright eHealth Insurance. Conference Call Slides 1 Safe Harbor Statement Forward-Looking Statements This presentation includes forward-looking statements within the meaning of the federal securities laws. Forward-loo

q12023earningsslidesfin Q1 2023 Financial Results 2023 Copyright eHealth Insurance.

May 1, 2023 DEFA14A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a party other than the Registrant ☐

DEFA14A 1 proxy2023noticeaccess.htm NOTICE & ACCESS UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, For Use of the Commission Only (as per

May 1, 2023 DEF 14A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a party other than the Registrant ☐

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, For Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☒ Definitive Proxy State

May 1, 2023 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (date of earliest event reported): April 28, 2023 EHEALTH, INC. (Exa

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (date of earliest event reported): April 28, 2023 EHEALTH, INC. (Exact Name of Registrant as Specified in its Charter) Delaware 001-33071 56-2357876 (State or other jurisdiction of incorporation) (Commission File Numbe

May 1, 2023 EX-99.1

eHealth, Inc. Reiterates Fiscal Year 2023 Guidance Ahead of First Quarter 2023 Earnings Announcement

eHealth, Inc. Reiterates Fiscal Year 2023 Guidance Ahead of First Quarter 2023 Earnings Announcement SANTA CLARA, Calif., April 28, 2023 – eHealth, Inc. (Nasdaq: EHTH), a leading private online health insurance marketplace, today reiterated its previously issued outlook for 2023. The company expects to achieve the following financial results for the full year ending December 31, 2023: •Total reven

May 1, 2023 ARS

ARS

eHealth, Inc. (Nasdaq: EHTH) is a leading private health insurance marketplace with a technology and service platform that provides consumer engagement, education and health insurance enrollment solutions. Our mission is to expertly guide consumers through their health insurance enrollment and related options, when, where, and how they prefer. Our platform leverages technology to solve a critical

March 1, 2023 10-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2022 ☐ TRANSITION REPORT PURSUANT TO SECTI

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-33071 EHEALTH, INC. (Exact name

March 1, 2023 EX-10.9

Severance Agreement, dated September 29, 2022 between Gavin Galimi and eHealth, Inc.

EHEALTH, INC. SEVERANCE AGREEMENT THIS SEVERANCE AGREEMENT (the “Agreement”) is by and between eHealth, Inc. (together with its subsidiary, eHealthInsurance Services, Inc., the “Company”) and Gavin Galimi (“Executive”). 1.AT-WILL EMPLOYMENT. Executive and the Company agree that Executive’s employment with Company constitutes “at-will” employment. Executive and the Company acknowledge that this emp

March 1, 2023 EX-10.10

Severance Agreement, dated October 20, 2022 between John Stelben and eHealth, Inc.

EHEALTH, INC. SEVERANCE AGREEMENT THIS SEVERANCE AGREEMENT (the “Agreement”) is by and between eHealth, Inc. (together with its subsidiary, eHealthInsurance Services, Inc., the “Company”) and John Stelben (“Executive”). 1.AT-WILL EMPLOYMENT. Executive and the Company agree that Executive’s employment with Company constitutes “at-will” employment. Executive and the Company acknowledge that this emp

February 28, 2023 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (date of earliest event reported): February 28, 2023 EHEALTH, INC. (

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (date of earliest event reported): February 28, 2023 EHEALTH, INC. (Exact Name of Registrant as Specified in its Charter) Delaware 001-33071 56-2357876 (State or other jurisdiction of incorporation) (Commission File Nu

February 28, 2023 EX-99.2

Q4 & FY 2022 Financial Results 12023 Copyright eHealth Insurance. Conference Call Slides Safe Harbor Statement 2 Forward-Looking Statements This presentation includes forward-looking statements within the meaning of the federal securities laws. Forwa

q42022earnslidesfinalv3 Q4 & FY 2022 Financial Results 12023 Copyright eHealth Insurance.

February 28, 2023 EX-99.1

eHealth, Inc. Announces Fourth Quarter and Fiscal Year 2022 Results

eHealth, Inc. Announces Fourth Quarter and Fiscal Year 2022 Results SANTA CLARA, California — February 28, 2023 — eHealth, Inc. (Nasdaq: EHTH), a leading private online health insurance marketplace, today announced its financial results for the fourth quarter and fiscal year ended December 31, 2022. Fourth Quarter 2022 Overview $196.3M $20.7M $49.5M TOTAL REVENUE GAAP NET INCOME ADJUSTED EBITDA(1)

February 14, 2023 SC 13G/A

EHTH / eHealth, Inc. / Palo Alto Investors LP Passive Investment

SC 13G/A 1 ehealthv6.txt UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULE 13d-1(b), (c), AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2(b) (AMENDMENT NO. 2)* eHealth, Inc. (Name of Issuer) Common Stock (Title of Class of Securities) 28238P109 (CUSIP Number) December 31, 2022 (Date of Ev

February 14, 2023 EX-99.A

Exhibit A

EX-99.A 2 ex-a.htm JOINT FILING AGREEMENT eHealth, Inc. SC 13G CUSIP No. 28238P109 13G Page 11 of 11 EXHIBIT A JOINT FILING AGREEMENT The undersigned hereby agree that the statement on Schedule 13G with respect to the common stock of eHealth, Inc., dated as of February 13, 2023 is, and any amendments thereto (including amendments on Schedule 13D) signed by each of the undersigned shall be, filed o

February 14, 2023 SC 13G

EHTH / eHealth, Inc. / 8 KNOTS MANAGEMENT, LLC - SCHEDULE FILED TO REPORT ACQUISITION OF BENEFICIAL OWNERSHIP Passive Investment

SC 13G 1 knots-sc13g020923.htm SCHEDULE FILED TO REPORT ACQUISITION OF BENEFICIAL OWNERSHIP UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* eHealth, Inc. (Name of Issuer) Common Stock, par value $0.001 per share (Title of Class of Securities) 28238P109 (CUSIP Number) December 31, 2022 (Date of Event Whic

February 9, 2023 SC 13G/A

EHTH / eHealth, Inc. / VANGUARD GROUP INC - SCHEDULE 13G/A Passive Investment

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 5)* Name of issuer: eHealth Inc. Title of Class of Securities: Common Stock CUSIP Number: 28238P109 Date of Event Which Requires Filing of this Statement: December 30, 2022 Check the appropriate box to designate the rule pursuant to which this Schedule is filed: ☒ Rule 1

February 8, 2023 8-K

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (date of earliest event reported): February 3, 2023 EHEALTH, INC. (Exact Name of Registrant as Specified in its Charter) Delaware 001-33071 56-2357876 (State or other jurisdiction of incorporation) (Commission File Num

February 8, 2023 EX-99.1

Randall Livingston to Transition from eHealth Board of Directors

PRESS RELEASE Randall Livingston to Transition from eHealth Board of Directors SANTA CLARA, Calif.

February 7, 2023 SC 13G

EHTH / eHealth, Inc. / GOLDMAN SACHS GROUP INC Passive Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* EHEALTH, INC. - (Name of Issuer) Common Stock, par value $0.001 per share - (Title of Class of Securities) 28238P109 - (CUSIP Number) December 30, 2022 - (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the ru

February 6, 2023 SC 13G/A

EHTH / eHealth, Inc. / BlackRock Inc. Passive Investment

SC 13G/A 1 us28238p1093020623.txt us28238p1093020623.txt SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No: 3) eHealth, Inc. - (Name of Issuer) Common Stock - (Title of Class of Securities) 28238P109 - (CUSIP Number) December 31, 2022 - (Date of Event Which Requires Filing of this Statement) Check the appropriate box to d

February 2, 2023 SC 13G

EHTH / eHealth, Inc. / Ruffer LLP Passive Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No.

January 24, 2023 EX-99.1

eHealth, Inc. Announces Preliminary Results for the Fourth Quarter and Fiscal Year 2022 Fourth quarter performance reflects significant increase in productivity of eHealth’s telesales operations

eHealth, Inc. Announces Preliminary Results for the Fourth Quarter and Fiscal Year 2022 Fourth quarter performance reflects significant increase in productivity of eHealth’s telesales operations SANTA CLARA, California, January 24, 2023 — eHealth, Inc. (Nasdaq: EHTH), a leading private online health insurance marketplace, today announced preliminary, unaudited financial results and select operatin

January 24, 2023 8-K

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (date of earliest event reported): January 24, 2023 EHEALTH, INC. (Exact Name of Registrant as Specified in its Charter) Delaware 001-33071 56-2357876 (State or other jurisdiction of incorporation) (Commission File Num

January 9, 2023 SC 13G/A

EHTH / eHealth, Inc. / MILLENNIUM MANAGEMENT LLC Passive Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (AMENDMENT NO. 1) EHEALTH, INC. (Name of Issuer) COMMON STOCK, PAR VALUE $0.001 PER SHARE (Title of Class of Securities) 28238P109 (CUSIP Number) DECEMBER 31, 2022 (Date of event which requires filing of this statement) Check the appropriate box to designate the rule pursu

December 19, 2022 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (date of earliest event reported): December 13, 2022 EHEALTH, INC. (

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (date of earliest event reported): December 13, 2022 EHEALTH, INC. (Exact Name of Registrant as Specified in its Charter) Delaware 001-33071 56-2357876 (State or other jurisdiction of incorporation) (Commission File Nu

December 19, 2022 EX-3.1

Amended and Restated Bylaws of the Registrant

EHEALTH, INC. AMENDED AND RESTATED BYLAWS (As Amended on December 13, 2022) ARTICLE I STOCKHOLDERS Section 1. Annual Meeting. (1) An annual meeting of the stockholders, for the election of directors to succeed those whose terms expire and for the transaction of such other business as may properly come before the meeting, shall be held at such place, if any, on such date, and at such time as the Bo

November 16, 2022 SC 13G

EHTH / eHealth, Inc. / MILLENNIUM MANAGEMENT LLC Passive Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 EHEALTH, INC. (Name of Issuer) COMMON STOCK, PAR VALUE $0.001 PER SHARE (Title of Class of Securities) 28238P109 (CUSIP Number) NOVEMBER 8, 2022 (Date of event which requires filing of this statement) Check the appropriate box to designate the rule pursuant to which this S

November 15, 2022 SC 13D/A

EHTH / eHealth, Inc. / Starboard Value LP - AMENDMENT NO. 3 TO THE SCHEDULE 13D Activist Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D (Rule 13d-101) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO ? 240.13d-1(a) AND AMENDMENTS THERETO FILED PURSUANT TO ? 240.13d-2(a) (Amendment No. 3)1 eHealth, Inc. (Name of Issuer) Common Stock, par value $0.001 per share (Title of Class of Securities) 28238P109 (CUSIP Number) JEFFREY C. SMITH STARBO

November 14, 2022 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (date of earliest event reported): November 8, 2022 EHEALTH, INC. (E

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (date of earliest event reported): November 8, 2022 EHEALTH, INC. (Exact Name of Registrant as Specified in its Charter) Delaware 001-33071 56-2357876 (State or other jurisdiction of incorporation) (Commission File Num

November 14, 2022 EX-99.1

eHealth, Inc. Appoints John Stelben as Chief Financial Officer Brings More Than 25 Years of Financial and Operational Experience to CFO Role; Succeeds Christine Janofsky Reaffirms Full Year Fiscal 2022 Guidance

PRESS RELEASE eHealth, Inc. Appoints John Stelben as Chief Financial Officer Brings More Than 25 Years of Financial and Operational Experience to CFO Role; Succeeds Christine Janofsky Reaffirms Full Year Fiscal 2022 Guidance SANTA CLARA, Calif., November 14, 2022 – eHealth, Inc. (Nasdaq: EHTH), a leading private online health insurance marketplace, today announced that it has appointed John Stelbe

November 8, 2022 S-8

As filed with the Securities and Exchange Commission on November 8, 2022

As filed with the Securities and Exchange Commission on November 8, 2022 Registration No.

November 8, 2022 EX-10.5

Amended and Restated 2014 Equity Incentive Plan

EHEALTH, INC. AMENDED AND RESTATED 2014 EQUITY INCENTIVE PLAN 1 TABLE OF CONTENTS Page ARTICLE 1. INTRODUCTION. 1 ARTICLE 2. ADMINISTRATION. 1 2.1 Administrator 1 2.2 Administrator Responsibilities 1 2.3 Committee for Non-Officer Grants 1 2.4 No Repricing 1 ARTICLE 3. SHARES AVAILABLE FOR GRANTS. 1 3.1 Basic Limitation 1 3.2 Shares Returned to Reserve 2 3.3 Dividend Equivalents 2 ARTICLE 4. ELIGIB

November 8, 2022 EX-FILING FEES

Filing Fee Table

Exhibit 107 Calculation of Filing Fee Table Form S-8 (Form Type) eHealth, Inc. (Exact Name of Registrant as Specified in its Charter) Table 1: Newly Registered Securities Security Type Security Class Title Fee Calculation Rule Amount Registered (1) Proposed Maximum Offering Price Per Unit Maximum Aggregate Offering Price Fee Rate Amount of Registration Fee Equity Common Stock, par value $0.001 per

November 8, 2022 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2022 ☐ TRANSITION REPORT PURSUANT

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2022 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-33071 EHEALTH, INC. (E

November 7, 2022 EX-99.2

November 7, 2022 Q3 2022 Financial Results Conference Call Slides The image part with relationship ID rId17 was not found in the file. Safe Harbor Statement 1 Forward-Looking Statements This presentation includes forward-looking statements within the

q32022earningsslidesfina November 7, 2022 Q3 2022 Financial Results Conference Call Slides The image part with relationship ID rId17 was not found in the file.

November 7, 2022 EX-99.1

eHealth, Inc. Announces Third Quarter 2022 Results

eHealth, Inc. Announces Third Quarter 2022 Results SANTA CLARA, California — November 7, 2022 — eHealth, Inc. (Nasdaq: EHTH), a leading private online health insurance marketplace, today announced its financial results for the third quarter ended September 30, 2022. Third Quarter 2022 Overview $53.4M $(39.1)M $(33.1)M TOTAL REVENUE GAAP NET LOSS ADJUSTED EBITDA(1) $(29.6)M 18% YoY $785.8M OPERATIN

November 7, 2022 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (date of earliest event reported): November 7, 2022 EHEALTH, INC. (E

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (date of earliest event reported): November 7, 2022 EHEALTH, INC. (Exact Name of Registrant as Specified in its Charter) Delaware 001-33071 56-2357876 (State or other jurisdiction of incorporation) (Commission File Num

October 7, 2022 SC 13G/A

EHTH / eHealth, Inc. / BlackRock Inc. Passive Investment

us28238p1093100622.txt SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No: 2) EHEALTH INC - (Name of Issuer) Common Stock - (Title of Class of Securities) 28238P109 - (CUSIP Number) September 30, 2022 - (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which

October 5, 2022 EX-10.1

Amended and Restated 2021 Inducement Plan

EHEALTH, INC. AMENDED AND RESTATED 2021 INDUCEMENT PLAN EHEALTH, INC. AMENDED AND RESTATED 2021 INDUCEMENT PLAN ARTICLE 1. INTRODUCTION. The Plan was established effective as of September 22, 2021, the date of its original approval by the Board (the ?Effective Date?), and was amended and restated as of March 17, 2022 and as of September 29, 2022. The Plan, through the granting of Awards, is intend

October 5, 2022 8-K

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (date of earliest event reported): September 29, 2022 EHEALTH, INC. (Exact Name of Registrant as Specified in its Charter) Delaware 001-33071 56-2357876 (State or other jurisdiction of incorporation) (Commission File N

September 26, 2022 SC 13G

RIGL / Rigel Pharmaceuticals, Inc. / MILLENNIUM MANAGEMENT LLC Passive Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 RIGEL PHARMACEUTICALS, INC. (Name of Issuer) COMMON STOCK, PAR VALUE $0.001 PER SHARE (Title of Class of Securities) 766559603 (CUSIP Number) SEPTEMBER 16, 2022 (Date of event which requires filing of this statement) Check the appropriate box to designate the rule pursuant

September 2, 2022 CORRESP

[REMAINDER OF PAGE INTENTIONALLY LEFT BLANK]

September 2, 2022 Re: eHealth, Inc. Registration Statement on Form S-3 Filed August 24, 2022 File No. 333-267048 Via EDGAR U.S. Securities and Exchange Commission Division of Corporation Finance Office of Finance 100 F Street, NE Washington, DC 20549 Attention: David Lin Dear Mr. Lin: In accordance with Rule 461 under the Securities Act of 1933, as amended, the undersigned registrant hereby reques

September 2, 2022 LETTER

LETTER

United States securities and exchange commission logo September 1, 2022 Francis Soistman Chief Executive Officer eHealth, Inc.

August 24, 2022 EX-4.3

Form of Indenture

Exhibit 4.3 EHEALTH, INC. INDENTURE Dated as of , 20 [] Trustee TABLE OF CONTENTS Page ARTICLE I DEFINITIONS AND INCORPORATION BY REFERENCE 1 Section 1.1 Definitions 1 Section 1.2 Other Definitions 4 Section 1.3 Incorporation by Reference of Trust Indenture Act 5 Section 1.4 Rules of Construction 5 ARTICLE II THE SECURITIES 5 Section 2.1 Issuable in Series 5 Section 2.2 Establishment of Terms of S

August 24, 2022 S-3

As filed with the Securities and Exchange Commission on August 24, 2022

As filed with the Securities and Exchange Commission on August 24, 2022 Registration No.

August 24, 2022 EX-FILING FEES

Filing Fee Table

Exhibit 107 CALCULATION OF FILING FEE TABLES FORM S-3 (Form Type) EHEALTH, INC. (Exact Name of Registrant as Specified in its Charter) Table 1: Newly Registered Securities Security Type Security Class Title Fee Calculation Rule Amount Registered Proposed Maximum Offering Price Per Unit Maximum Aggregate Offering Price Fee Rate Amount of Registration Fee Fees to Be Paid Equity Common stock, par val

August 22, 2022 8-K

Entry into a Material Definitive Agreement, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (date of earliest event reported): August 16, 2022 EHEALTH, INC. (Exact Name of Registrant as Specified in its Charter) Delaware 001-33071 56-2357876 (State or other jurisdiction of incorporation) (Commission File Numb

August 22, 2022 EX-10.1

First Amendment to Credit Agreement, dated August 16, 2022, by and among eHealth, Inc., Blue Torch Finance LLC and the lenders identified therein

Execution Version AMENDMENT TO CREDIT AGREEMENT This AMENDMENT TO CREDIT AGREEMENT dated as of August 16, 2022 (this ?Amendment?), is entered into among EHEALTH, INC.

August 9, 2022 EX-10.3

Consent to Subletting, dated August 8, 2022, by and among Augustine Bowers LLC, eHealthInsurance Services, Inc. and SiFive, Inc.

CONSENT TO SUBLETTING I. PARTIES AND DATES. This Consent to Subletting ("Consent") dated August 8, 2022, is by and between AUGUSTINE BOWERS LLC, a Delaware limited liability company ("Landlord"), EHEALTHINSURANCE SERVICES, INC., a Delaware corporation ("Tenant"), and SIFIVE, INC., a Delaware corporation ("Subtenant"). II. RECITALS. On April 25, 2018, Landlord and Tenant entered into an office spac

August 9, 2022 EX-FILING FEES

Filing Fee Table

Exhibit 107 Calculation of Filing Fee Table Form S-8 (Form Type) eHealth, Inc. (Exact Name of Registrant as Specified in its Charter) Table 1: Newly Registered Securities Security Type Security Class Title Fee Calculation Rule Amount Registered (1) Proposed Maximum Offering Price Per Unit Maximum Aggregate Offering Price Fee Rate Amount of Registration Fee Equity Common Stock, par value $0.001 per

August 9, 2022 EX-10.2

Sublease, dated July 11, 2022, between SiFive, Inc. and eHealthInsurance Services, Inc.

SUBLEASE THIS SUBLEASE (this ?Sublease?) is dated for reference purposes as of July 11, 2022, and is made by and between EHEALTHINSURANCE SERVICES, INC.

August 9, 2022 8-K/A

Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K/A (Amendment No. 1) CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (date of earliest event reported): August 3, 2022 EHEALTH, INC. (Exact Name of Registrant as Specified in its Charter) Delaware 001-33071 56-2357876 (State or other jurisdiction of incorporation) (C

August 9, 2022 S-8

As filed with the Securities and Exchange Commission on August 8, 2022

As filed with the Securities and Exchange Commission on August 8, 2022 Registration No.

August 9, 2022 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2022 ☐ TRANSITION REPORT PURSUANT TO S

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2022 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-33071 EHEALTH, INC. (Exact

August 8, 2022 8-K

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (date of earliest event reported): August 3, 2022 EHEALTH, INC. (Exact Name of Registrant as Specified in its Charter) Delaware 001-33071 56-2357876 (State or other jurisdiction of incorporation) (Commission File Numbe

August 8, 2022 EX-99.1

eHealth, Inc. Announces Second Quarter 2022 Results

eHealth, Inc. Announces Second Quarter 2022 Results SANTA CLARA, California ? August 8, 2022 ? eHealth, Inc. (Nasdaq: EHTH), a leading private online health insurance marketplace, today announced its financial results for the second quarter ended June 30, 2022. Second Quarter 2022 Overview $50.4M* $(37.5)M* $(33.3)M* TOTAL REVENUE GAAP NET LOSS ADJUSTED EBITDA(1) $(25.8)M 15% YoY $801.6M OPERATING

August 8, 2022 EX-99.2

August 8, 2022 Q2 2022 Financial Results Conference Call Slides The image part with relationship ID rId17 was not found in the file. Safe Harbor Statement 1 Forward-Looking Statements This presentation includes forward-looking statements within the m

August 8, 2022 Q2 2022 Financial Results Conference Call Slides The image part with relationship ID rId17 was not found in the file.

June 21, 2022 8-K

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits, Submission of Matters to a Vote of Security Holders

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (date of earliest event reported): June 15, 2022 EHEALTH, INC. (Exact Name of Registrant as Specified in its Charter) Delaware 001-33071 56-2357876 (State or other jurisdiction of incorporation) (Commission File Number

June 21, 2022 EX-10.1

Amended and Restated 2014 Equity

EHEALTH, INC. AMENDED AND RESTATED 2014 EQUITY INCENTIVE PLAN TABLE OF CONTENTS Page ARTICLE 1. INTRODUCTION. 1 ARTICLE 2. ADMINISTRATION. 1 2.1 Administrator 1 2.2 Administrator Responsibilities 1 2.3 Committee for Non-Officer Grants 1 2.4 No Repricing 1 ARTICLE 3. SHARES AVAILABLE FOR GRANTS. 1 3.1 Basic Limitation 1 3.2 Shares Returned to Reserve 2 3.3 Dividend Equivalents 2 ARTICLE 4. ELIGIBIL

June 2, 2022 8-K

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (date of earliest event reported): May 31, 2022 EHEALTH, INC. (Exact Name of Registrant as Specified in its Charter) Delaware 001-33071 56-2357876 (State or other jurisdiction of incorporation) (Commission File Number)

May 11, 2022 DEFA14A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a party other than the Registrant ☐

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ? Filed by a party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, For Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ? Definitive Proxy State

May 6, 2022 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2022 ☐ TRANSITION REPORT PURSUANT TO

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2022 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-33071 EHEALTH, INC. (Exact

May 6, 2022 EX-10.4

Agreement, dated February 22, 2022, between Roman Rariy and eHealth, Inc.

Sign-On & Retention Bonus Repayment Agreement Dear Roman, Please review this Sign-On and Retention Bonus (?Bonus?) Repayment Agreement (?Agreement?).

May 6, 2022 EX-10.3

Severance Agreement, dated February 22, 2022 between Roman Rariy and eHealth, Inc.

EHEALTH, INC. SEVERANCE AGREEMENT This Severance Agreement (the ?Agreement?) is by and between eHealth, Inc. (together with its subsidiary, eHealthInsurance Services, Inc., the ?Company?) and Roman Rariy (?Executive?). 1.At-Will Employment. Executive and the Company agree that Executive?s employment with Company constitutes ?at-will? employment. Executive and the Company acknowledge that this empl

May 3, 2022 EX-99.2

May 3, 2022 Q1 2022 Financial Results Conference Call Slides The image part with relationship ID rId17 was not found in the file. Safe Harbor Statement 1 Forward-Looking Statements This presentation includes forward-looking statements within the mean

May 3, 2022 Q1 2022 Financial Results Conference Call Slides The image part with relationship ID rId17 was not found in the file.

May 3, 2022 EX-99.1

eHealth, Inc. Announces First Quarter 2022 Results

eHealth, Inc. Announces First Quarter 2022 Results SANTA CLARA, California ? May 3, 2022 ? eHealth, Inc. (Nasdaq: EHTH), a leading private online health insurance marketplace, today announced its financial results for the first quarter ended March 31, 2022. First Quarter 2022 Overview $105.3M $(32.7)M $(24.8)M TOTAL REVENUE GAAP NET LOSS ADJUSTED EBITDA (1) $47.1M +50% YoY $831.2M OPERATING CASH F

May 3, 2022 8-K

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (date of earliest event reported): May 3, 2022 EHEALTH, INC. (Exact Name of Registrant as Specified in its Charter) Delaware 001-33071 56-2357876 (State or other jurisdiction of incorporation) (Commission File Number)

May 2, 2022 DEFA14A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a party other than the Registrant ☐

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ? Filed by a party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, For Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ? Definitive Proxy State

May 2, 2022 DEF 14A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a party other than the Registrant ☐

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ? Filed by a party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, For Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ? Definitive Proxy State

March 22, 2022 EX-FILING FEES

Filing Fee Table

Exhibit 107 Calculation of Filing Fee Table Form S-8 (Form Type) eHealth, Inc. (Exact Name of Registrant as Specified in its Charter) Table 1: Newly Registered Securities Security Type Security Class Title Fee Calculation Rule Amount Registered (1) Proposed Maximum Offering Price Per Unit Maximum Aggregate Offering Price Fee Rate Amount of Registration Fee Equity Common Stock, par value $0.001 per

March 22, 2022 S-8

As filed with the Securities and Exchange Commission on March 22, 2022

As filed with the Securities and Exchange Commission on March 22, 2022 Registration No.

March 18, 2022 8-K

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (date of earliest event reported): March 17, 2022 EHEALTH, INC. (Exact Name of Registrant as Specified in its Charter) Delaware 001-33071 56-2357876 (State or other jurisdiction of incorporation) (Commission File Numbe

March 18, 2022 EX-10.1

Amended and Restated 2021 Inducement Plan

EHEALTH, INC. AMENDED AND RESTATED 2021 INDUCEMENT PLAN EHEALTH, INC. AMENDED AND RESTATED 2021 INDUCEMENT PLAN ARTICLE 1. INTRODUCTION. The Plan was established effective as of September 22, 2021, the date of its original approval by the Board (the ?Effective Date?), and was amended and restated as of March 17, 2022. The Plan, through the granting of Awards, is intended to provide a material indu

March 11, 2022 SC 13D/A

EHTH / eHealth, Inc. / Hudson Executive Capital LP - SCHEDULE 13D (AMENDMENT NO. 2) Activist Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 2) eHealth, Inc. (Name of Issuer) Common Stock, $0.001 par value (Title of Class of Securities) 28238P109 (CUSIP Number) Michael D. Pinnisi Hudson Executive Capital LP c/o Cadwalader, Wickersham & Taft LLP 200 Liberty Street (212) 521-8495 Copies to: Richard

March 11, 2022 EX-4

Exhibit 4

EXHIBIT 4 Schedule of Transactions in Shares The following table sets forth all transactions with respect to Shares effected by the Reporting Persons or on behalf of the Reporting Persons in respect of the Shares during the past sixty days.

March 2, 2022 EX-99.1

Fourth Quarter 2021 Overview $243.5M $(32.2)M $28.2M REVENUE GAAP NET LOSS ADJUSTED EBITDA (1) (2) (18)% YoY +53% YoY $908M MEDICARE ADVANTAGE APPROVED MEMBERS MAJOR MEDICARE (3) APPLICATIONS SUBMITTED ONLINE UNASSISTED COMMISSIONS RECEIVABLE BALANCE

/C O R R E C T I O N - eHealth, Inc./ eHealth, Inc. is correcting misstatements regarding guidance for GAAP net loss for the full year ending December 31, 2022 in its earnings press release for the fourth quarter and year ended December 31, 2021 that was issued on March 1, 2022. The misstatements did not impact eHealth?s GAAP financial statements. The guidance for GAAP net loss for the full year e

March 2, 2022 8-K/A

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K/A (Amendment No. 1) CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (date of earliest event reported): March 1, 2022 EHEALTH, INC. (Exact Name of Registrant as Specified in its Charter) Delaware 001-33071 56-2357876 (State or other jurisdiction of incorporation) (Co

March 2, 2022 EX-FILING FEES

Filing Fee Table

Exhibit 107 Calculation of Filing Fee Tables Post-Effective Amendment to Form S-3ASR (Form Type) eHealth, Inc.

March 2, 2022 EX-99.2

March 1, 2022 Q4 & FY 2021 Financial Results Conference Call Slides The image part with relationship ID rId17 was not found in the file. Safe Harbor Statement 1 Forward-Looking Statements This presentation includes forward-looking statements within t

March 1, 2022 Q4 & FY 2021 Financial Results Conference Call Slides The image part with relationship ID rId17 was not found in the file.

March 2, 2022 POS AM

As filed with the Securities and Exchange Commission on March 1, 2022

As filed with the Securities and Exchange Commission on March 1, 2022 Registration No.

March 1, 2022 10-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2021 ☐ TRANSITION REPORT PURSUANT TO SECTI

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K ? ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2021 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-33071 EHEALTH, INC. (Exact name

March 1, 2022 EX-FILING FEES

Filing Fee Table

Exhibit 107 Calculation of Filing Fee Tables Post-Effective Amendment to Form S-3ASR (Form Type) eHealth, Inc.

March 1, 2022 EX-4.2

Description of Capital Stock

Exhibit 4.2 DESCRIPTION OF THE REGISTRANT?S SECURITIES REGISTERED PURSUANT TO SECTION 12 OF THE SECURITIES EXCHANGE ACT OF 1934 eHealth, Inc. has one class of securities registered under Section 12 of the Securities Exchange Act of 1934, as amended: our common stock, $0.001 par value per share. The following description summarizes the general terms and provisions of our capital stock as set forth

March 1, 2022 EX-99.1

eHealth, Inc. Announces Fourth Quarter and Fiscal Year 2021 Results

eHealth, Inc. Announces Fourth Quarter and Fiscal Year 2021 Results SANTA CLARA, California ? March 1, 2022 ? eHealth, Inc. (Nasdaq: EHTH), a leading private online health insurance marketplace, today announced its financial results for the fourth quarter and fiscal year ended December 31, 2021. Fourth Quarter 2021 Overview $243.5M $(32.2)M $28.2M REVENUE GAAP NET LOSS ADJUSTED EBITDA (1) (2) (18)

March 1, 2022 EX-99.2

March 1, 2022 Q4 & FY 2021 Financial Results Conference Call Slides The image part with relationship ID rId17 was not found in the file. Safe Harbor Statement 1 Forward-Looking Statements This presentation includes forward-looking statements within t

March 1, 2022 Q4 & FY 2021 Financial Results Conference Call Slides The image part with relationship ID rId17 was not found in the file.

March 1, 2022 8-K

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (date of earliest event reported): March 1, 2022 EHEALTH, INC. (Exact Name of Registrant as Specified in its Charter) Delaware 001-33071 56-2357876 (State or other jurisdiction of incorporation) (Commission File Number

March 1, 2022 POSASR

As filed with the Securities and Exchange Commission on February 28, 2022

As filed with the Securities and Exchange Commission on February 28, 2022 Registration No.

February 28, 2022 8-K

Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement, Financial Statements and Exhibits, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (date of earliest event reported): February 28, 2022 EHEALTH, INC. (Exact Name of Registrant as Specified in its Charter) Delaware 001-33071 56-2357876 (State or other jurisdiction of incorporation) (Commission File Nu

February 28, 2022 EX-99.1

eHealth Hires Roman Rariy as Chief Operating Officer and Chief Transformation Officer Rariy to lead strategic initiatives to strengthen, refocus the business and to achieve operational excellence; comes to eHealth from Lionbridge and the Kraft Heinz

PRESS RELEASE eHealth Hires Roman Rariy as Chief Operating Officer and Chief Transformation Officer Rariy to lead strategic initiatives to strengthen, refocus the business and to achieve operational excellence; comes to eHealth from Lionbridge and the Kraft Heinz Company SANTA CLARA, CA ? February 28, 2022 ? eHealth, Inc.

February 28, 2022 EX-10.1

Credit Agreement, dated February 28, 2022, by and among eHealth, Inc., Blue Torch Finance LLC and the other lenders identified therein.

Execution Version CREDIT AGREEMENT Dated as of February 28, 2022 among EHEALTH, INC.

February 28, 2022 8-K

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (date of earliest event reported): February 28, 2022 EHEALTH, INC. (Exact Name of Registrant as Specified in its Charter) Delaware 001-33071 56-2357876 (State or other jurisdiction of incorporation) (Commission File Nu

February 14, 2022 SC 13G/A

EHTH / eHealth, Inc. / Palo Alto Investors LP Passive Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULE 13d-1(b), (c), AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2(b) (AMENDMENT NO. 1)* eHealth, Inc. (Name of Issuer) Common Stock (Title of Class of Securities) 28238P109 (CUSIP Number) December 31, 2021 (Date of Event which Requires Filing

February 9, 2022 SC 13G/A

EHTH / eHealth, Inc. / VANGUARD GROUP INC - SCHEDULE 13G/A Passive Investment

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 4)* Name of issuer: eHealth Inc. Title of Class of Securities: Common Stock CUSIP Number: 28238P109 Date of Event Which Requires Filing of this Statement: December 31, 2021 Check the appropriate box to designate the rule pursuant to which this Schedule is filed: ☒ Rule 1

January 31, 2022 8-K

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (date of earliest event reported): January 31, 2022 EHEALTH, INC. (Exact Name of Registrant as Specified in its Charter) Delaware 001-33071 56-2357876 (State or other jurisdiction of incorporation) (Commission File Num

January 28, 2022 SC 13G/A

EHTH / eHealth, Inc. / BlackRock Inc. Passive Investment

us28238p1093012822.txt SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No: 1) EHEALTH INC - (Name of Issuer) Common Stock - (Title of Class of Securities) 28238P109 - (CUSIP Number) December 31, 2021 - (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which

January 10, 2022 SC 13G/A

EHTH / eHealth, Inc. / FMR LLC Passive Investment

SCHEDULE 13G Amendment No. 2 EHEALTH INC COMMON STOCK Cusip #28238P109 Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [x] Rule 13d-1(b) [ ] Rule 13d-1(c) [ ] Rule 13d-1(d) Cusip #28238P109 Item 1: Reporting Person - FMR LLC Item 2: (a) [ ] (b) [ ] Item 4: Delaware Item 5: 0 Item 6: 0 Item 7: 22 Item 8: 0 Item 9: 22 Item 11: 0.000% Item 12: HC Cusip #28238

January 7, 2022 SC 13D/A

EHTH / eHealth, Inc. / Starboard Value LP - AMENDMENT NO. 2 TO THE SCHEDULE 13D Activist Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D (Rule 13d-101) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO ? 240.13d-1(a) AND AMENDMENTS THERETO FILED PURSUANT TO ? 240.13d-2(a) (Amendment No. 2)1 eHealth, Inc. (Name of Issuer) Common Stock, par value $0.001 per share (Title of Class of Securities) 28238P109 (CUSIP Number) JEFFREY C. SMITH STARBO

January 6, 2022 8-K

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (date of earliest event reported): December 31, 2021 EHEALTH, INC. (Exact Name of Registrant as Specified in its Charter) Delaware 001-33071 56-2357876 (State or other jurisdiction of incorporation) (Commission File Nu

December 17, 2021 8-K

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (date of earliest event reported): December 13, 2021 EHEALTH, INC. (Exact Name of Registrant as Specified in its Charter) Delaware 001-33071 56-2357876 (State or other jurisdiction of incorporation) (Commission File Nu

December 17, 2021 EX-3.1

Amended and Restated Bylaws of the Registrant

EX-3.1 2 exhibit31amendedandrestate.htm EX-3.1 EHEALTH, INC. AMENDED AND RESTATED BYLAWS (As Amended on December 13, 2021) ARTICLE I STOCKHOLDERS Section 1. Annual Meeting. (1) An annual meeting of the stockholders, for the election of directors to succeed those whose terms expire and for the transaction of such other business as may properly come before the meeting, shall be held at such place, i

December 17, 2021 EX-10.1

Employment Agreement, dated December 13, 2021, between Fran Soistman and eHealth, Inc.

EHEALTH, INC. EMPLOYMENT AGREEMENT This Employment Agreement (the ?Agreement?) is entered into by and between eHealth, Inc. (the ?Company?) and Fran Soistman (?Executive?). 1.Duties and Scope of Employment. (a)Positions and Duties. Effective as of September 22, 2021 (the ?Start Date?), Executive has become an employee of the Company. Effective November 1, 2021, Executive began serving as the Compa

November 18, 2021 8-K

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (date of earliest event reported): November 15, 2021 EHEALTH, INC. (Exact Name of Registrant as Specified in its Charter) Delaware 001-33071 56-2357876 (State or other jurisdiction of incorporation) (Commission File Nu

November 10, 2021 8-K

Regulation FD Disclosure

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (date of earliest event reported): November 8, 2021 EHEALTH, INC. (Exact Name of Registrant as Specified in its Charter) Delaware 001-33071 56-2357876 (State or other jurisdiction of incorporation) (Commission File Num

November 8, 2021 EX-99.2

November 8, 2021 Q3 2021 Financial Results Conference Call Slides The image part with relationship ID rId17 was not found in the file. Safe Harbor Statement 1 Forward-Looking Statements This presentation includes forward-looking statements within the

November 8, 2021 Q3 2021 Financial Results Conference Call Slides The image part with relationship ID rId17 was not found in the file.

November 8, 2021 EX-10.9

Severance Agreement, dated June 5, 2020, between John Pierantoni and eHealth, Inc.

EX-10.9 5 exhibit109johnpierantonise.htm EX-10.9 eHealthInsurance Services, Inc. 2625 Augustine Drive, Second Floor Santa Clara, CA 95054 June 5, 2020 John Pierantoni Dear John: I am pleased to offer you a severance agreement with eHealthInsurance Services, Inc. (the “Company”) based on the terms described in this letter agreement (the “Letter”) and the attached Appendix A (which is incorporated b

November 8, 2021 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2021 ☐ TRANSITION REPORT PURSUANT

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2021 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-33071 EHEALTH, INC. (E

November 8, 2021 EX-10.7

Separation and Consulting Agreement, dated September 22, 2021, between Scott N. Flanders and eHealth, Inc.

SEPARATION AGREEMENT AND RELEASE This Separation Agreement and Release (?Agreement?) is made by and between Scott N.

November 8, 2021 EX-10.6

Terms of Executive Employment Agreement, dated September 22, 2021, between Fran Soistman and eHealth, Inc.

Terms of Executive Employment Agreement The following term sheet (the ?Term Sheet?) sets forth the terms for the employment of Fran Soistman (?Executive?) as the Chief Executive Officer of eHealth, Inc.

November 8, 2021 8-K

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (date of earliest event reported): November 8, 2021 EHEALTH, INC. (Exact Name of Registrant as Specified in its Charter) Delaware 001-33071 56-2357876 (State or other jurisdiction of incorporation) (Commission File Num

November 8, 2021 EX-99.1

eHealth, Inc. Announces Third Quarter 2021 Results

eHealth, Inc. Announces Third Quarter 2021 Results SANTA CLARA, California ? November 8, 2021 ? eHealth, Inc. (Nasdaq: EHTH), a leading private online health insurance marketplace, today announced its financial results for the third quarter ended September 30, 2021. $63.9M $(53.0)M $(55.2)M REVENUE GAAP NET LOSS ADJUSTED EBITDA (1) (2) (18)% YoY +58% YoY +88 % YoY MEDICARE ADVANTAGE APPROVED MEMBE

How Much do you Like Fintel?
Please share your opinion of our service!
Excellent Bad
Other Listings
DE:M5V 1,31 €
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista